By Newswise A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 percent, […]
Research shows many with mild COVID-19 infections still experience long-term symptoms
By Newswise The majority of individuals who experience mild or moderate COVID-19 infection also experience long COVID, or persistent symptoms more than 30 days after they test positive, according to […]
Medical researchers rethinking remdesivir
By Newswise Remdesivir is an antiviral drug originally discovered as part of a program to develop antiviral agents with activity against novel emerging viruses. In the first months of the […]
Gene mutation weakens virus-fighting protein in the gut causing rare inflammatory bowel disease
By Newswise Johns Hopkins Medicine researchers, in collaboration with national and international researchers, have identified a genetic mutation in a small number of children with a rare type of inflammatory […]
Mayo research provides insights into high-risk younger demographics for severe COVID-19
(Newswise)–Using data from 9,859 COVID-19 infections, Mayo Clinic researchers have new insights into risk factors for younger populations, some of which differ significantly from their older counterparts. People younger than 45 had a greater […]
75% of sexual assault survivors have PTSD one month later
(Newswise)–Researchers want sexual assault survivors to know that it’s normal to feel awful right after the assault, but that many will feel better within three months. In a meta-analysis published in Trauma, […]
Early CA Health Interview Survey data estimates show how Californians dealt with COVID-19
by Elaiza Torralba (Newswise)–With California state vaccination rates slowing, and guidelines on mask wearing and social gatherings changing, the UCLA Center for Health Policy Research (CHPR) has released new data […]
No sign of COVID-19 vaccine in breast milk
(Newswise)–Messenger RNA vaccines against COVID-19 were not detected in human milk, according to a small study by UC San Francisco, providing early evidence that the vaccine mRNA is not transferred […]
A promising new pathway to treating type 2 diabetes
(Newswise)–This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that transformed Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, from a terminal […]
Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
(Newswise)–Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize […]